- Home
- BAC vs MRK Comparison
BAC vs MRK Comparison
Compare BAC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BAC | MRK |
|---|---|---|
| Founded | 1784 | 2000 |
| Country | United States | United States |
| Employees | 213000 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.7B | 317.8B |
| IPO Year | 2025 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BAC | MRK |
|---|---|---|
| Price | $53.69 | $143.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 28 |
| Target Price | $68.62 | ★ $154.62 |
| AVG Volume (30 Days) | ★ 28.3M | 5.2M |
| Earning Date | 10-14-2026 | 10-29-2026 |
| Dividend Yield | ★ 2.35% | 2.34% |
| EPS Growth | ★ 18.69 | 8.01 |
| EPS | ★ 2.31 | N/A |
| Revenue | ★ $113,097,000,000.00 | $65,011,000,000.00 |
| Revenue This Year | $9.52 | $3.29 |
| Revenue Next Year | $5.28 | $4.59 |
| P/E Ratio | $23.82 | ★ N/A |
| Revenue Growth | ★ 11.00 | 1.31 |
| 52 Week Low | $46.12 | $82.01 |
| 52 Week High | $65.23 | $157.00 |
Technical Indicators
Market Signals| Indicator | BAC | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 21.75 | 46.44 |
| Support Level | $51.19 | $142.32 |
| Resistance Level | $55.40 | $153.19 |
| Average True Range (ATR) | 1.15 | 3.19 |
| MACD | -0.41 | -0.73 |
| Stochastic Oscillator | 4.46 | 18.84 |
Price Performance
Historical ComparisonAbout BAC Bank of America Corporation
Bank of America is a formidable financial titan with a $3.5 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).